Ozurdex(Dexamethasone Intravitreal Implant)
OZURDEX Rx
Generic Name and Formulations:
Dexamethasone 0.7mg in the Novadur delivery system; intravitreal implant; preservative-free.
Company:
Allergan
Select therapeutic use: Miscellaneous ocular agents
Indications for OZURDEX:
Macular edema following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO). Non-infectious uveitis affecting the posterior segment of the eye. Diabetic macular edema.
Adult:
For ophthalmic intravitreal injection only. One implant in each affected eye(s).
Children:
Not established.
Contraindications:
Ocular or periocular infections. Glaucoma (cup to disc ratio >0.8). Torn or ruptured posterior lens capsule.
Warnings/Precautions:
Monitor for intravitreal injection-related effects (eg, endophthalmitis, eye inflammation, increased intraocular pressure, retinal detachments) following the injection. Risk of potential steroid-related effects (eg, posterior subcapsular cataracts, glaucoma, secondary ocular infections). History of ocular herpes simplex: not recommended. Risk of implant migration to anterior chamber if posterior lens capsule is not intact. Pregnancy (Cat.C). Nursing mothers.
Pharmacological Class:
Corticosteroid.
Adverse Reactions:
Increased intraocular pressure, conjunctival hemorrhage, eye pain, conjunctival hyperemia, ocular hypertension, cataracts.
How Supplied:
Single-use intravitreal implant—1 (w. applicator) |
